Try our solution

ABSCINT’s 68Ga-HER2 tracer is currently in a PHASE IIb clinical study in Belgium. To maximize the potential of unlocking the full clinical use of the HER2 tracer, ABSCINT offers the possibility to academic institutes/hospitals/companies to access our GMP grade precursor for investigator-initiated trials.

Please complete the form below when interested.

What we offer

Gain access to GMP grade precursor

Technical support for the radiopharmacy

Documentation to support trial application


Do you have questions about our solution, contact us. We are here to help.